Exelixis Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
298.04 M |
Public Float |
255.61 M |
Exelixis Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.08 |
Market Cap |
$6.37 B |
Shares Outstanding |
301.77 M |
Public Float |
289.93 M |
Address |
1851 Harbor Bay Parkway Alameda California 94502 United States |
Employees | - |
Website | http://www.exelixis.com |
Updated | 07/08/2019 |
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. |